Syra Health Turns Profitable in Q1 2026, Reports $241K Net Income and Strong Margin Expansion
Summary
Syra Health Corp. announced its first-ever profitable quarter in Q1 2026, reporting a net income of $241,000, a substantial improvement from a loss in the prior year. The company also achieved a 22% increase in total revenue to $2.3 million and expanded its gross margin by 11 percentage points to 42.7%. This milestone is highly significant for a micro-cap company, indicating a fundamental shift in its financial health and operational efficiency. While the company anticipates some quarterly variability due to milestone-based contracts, it remains on track for full-year profitability. This positive development could lead to a significant re-evaluation of the stock by investors, who will now be watching for sustained profitability and continued growth in its healthcare solutions.
At the time of this announcement, SYRA was trading at $0.45 on OTC in the Life Sciences sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $0.03 to $0.70. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.